Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics
Pharmacology
[키워드] arrhythmia
Arrhythmias
Azithromycin
cardiac
Cardiomyocytes
Clinical findings
clinical measurement
clinical trial
clinically
clinician
Combination
combined efficacy
COVID-19
debate
drug
drug response
Drug screening
drugs
effective
effective drugs
effort
Emergency use authorization
evaluate
events
Evidence
FDA
Frequency
global efforts
HCQ
heart
heart muscle
Hospitalization
hospitalized COVID-19 patients
Hydroxychloroquine
identify
increase in
induced pluripotent stem cells
Microphysiological systems
MPS
muscle
platform
pluripotent stem cell
polytherapy
predict
predicted
prediction
Premature
QT interval
QT prolongation
reflected
resource
Safe
SARS-CoV-2
SARS-CoV-2 pandemic
significant increase
System
Therapeutics
time-consuming
tissue
treat
treated
treatment for COVID-19
was measured
while
worsening
[DOI] 10.3389/fphar.2021.684252 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.684252 PMC 바로가기 [Article Type] Pharmacology